This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Douglas Phillips
Senior Scientist, Antibody Discovery at Mabylon


As Senior Scientist, Antibody Discovery at Mabylon AG in Zurich, Doug Phillips focuses on the discovery of novel human-derived antibody therapeutics to address several unmet medical needs in the treatment of allergies and neurological disorders. He received his PhD in antibody discovery from the University of Reading and has developed extensive experience in the discovery and engineering of antibodies, alternative scaffolds and scFvs for use as therapeutics.

Agenda Sessions

  • Unlocking the Potential of Human-derived Antibodies